Stock Taper Revenue: $5.6 million for Q2 2026, a significant increase from $61,000 in Q2 2025 and $3.7 million in Q1 2026.
Operating Expenses: $21.8 million, up 114% year-over-year, primarily due to increased personnel costs and acquisition-related expenses of approximately $7.3 million.
Net Loss: $11.8 million ($0.05 per share), improved from a net loss of $36.5 million ($0.26 per share) in the prior year, mainly due to a reduction in noncash losses related to a derivative liability.
Total Assets: Approximately $1.6 billion, with cash and equivalents at around $1.3 billion, down from $1.5 billion at year-end 2025.
Liabilities: Total liabilities increased to $47.2 million, up $26.5 million compared to year-end 2025.
Contract Backlog: Approximately $42.5 million as of June 30, 2026.
QCI is focusing on scalable, cost-effective production of miniaturized quantum products, leveraging advancements in nanophotonics and advanced packaging.
The company completed three strategic acquisitions, enhancing its technical capabilities and manufacturing capacities, including the acquisition of Enhanced Semiconductor, which accelerates their Fab-2 initiative.
The Neurawave photonic reservoir computing platform reached commercial readiness, targeting applications in AI, telecommunications, and defense.
Successful deployment of the Dirac-3 quantum optimization machine at a global consulting firm, indicating growing interest in practical quantum solutions.
Expansion of the quantum communication portfolio with a purchase order from a leading university for a quantum secure communications system.
QCI aims to continue integrating recent acquisitions and expanding its manufacturing capabilities to meet growing demand.
The company is focused on commercializing quantum technologies while enhancing its portfolio of photonic components and semiconductor manufacturing services.
Management expressed confidence in the commercial and government contract pipeline, with plans to evaluate further acquisition opportunities to strengthen their position.
Operating expenses are significantly increasing, raising concerns about cost management amidst rapid growth.
The company faces inherent challenges in project delivery timelines due to the complexity of cutting-edge development work, making revenue predictions difficult.
The backlog is expected to remain stable but may not see rapid turnover, as contracts are typically long-term (12-18 months).
Competitive pressures in the quantum computing space were acknowledged, with ongoing development challenges related to quantum gate technology.
Management confirmed that approximately 70-80% of current business comes from government contracts, primarily as subcontractors, with a gradual shift expected towards commercial markets.
The Dirac-3 machine has shown advantages over classical and other quantum machines, but further functionality enhancements are needed for wider adoption.
The company is planning to invest in expanding its sales force to capitalize on market opportunities, indicating readiness to scale operations significantly.
The CFO noted that while Enhanced Semiconductor's past revenue contributions are variable, they expect to maintain cautious optimism regarding future performance. Overall, QUBT is positioned for growth with a strong focus on integrating new technologies and expanding its market presence, despite facing challenges related to operating costs and project timelines.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT